Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shay Menascu

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of the Neurological Sciences|December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stageShay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021Anat Achiron, Mark Dolev, Shay Menascu, et al.
Journal of the Neurological Sciences|January 29, 2022
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster doseSapir Dreyer-Alster, Shay Menascu, Mathilda Mandel, et al.
Cell Reports. Medicine|May 5, 2021
Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysisIzhak Levi, Michael Gurevich, Gal Perlman, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of the Neurological Sciences|December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stageShay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021Anat Achiron, Mark Dolev, Shay Menascu, et al.
Journal of the Neurological Sciences|January 29, 2022
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster doseSapir Dreyer-Alster, Shay Menascu, Mathilda Mandel, et al.
Cell Reports. Medicine|May 5, 2021
Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysisIzhak Levi, Michael Gurevich, Gal Perlman, et al.
Pageof 8